文献速递神经肿瘤

内镜经眶入路治疗蝶眶肿瘤:病例系列及文献系统综述

Endoscopic Transorbital Approach for Spheno-Orbital Tumors: Case Series and Systematic Review of Literature.
PubMed 文献 · World Neurosurg · 2023-06-16

该研究分析了内镜经眶入路(eTOA)治疗蝶眶肿瘤的作用,报告了本机构2016至2022年22例患者的临床系列结果,并进行系统文献综述。结果显示eTOA联合多阶段策略可提高肿瘤全切除率,并发症少,恢复快,但技术难度大,应在专门中心开展。

要点

  • 本系列22例蝶眶肿瘤患者中,eTOA术后全切除8例(36.4%),联合内镜经鼻多阶段策略后全切除11例(50.0%)。
  • 最常见组织学类型为脑膜瘤(86.4%),突眼均改善,视力缺陷改善66.6%,复视改善76.9%。
  • 并发症包括1例慢性硬膜下血肿和1例永久性眼外肌缺陷,平均出院时间2.4±1.3天。

核心结论

  • eTOA治疗蝶眶病变的主要优点是患者预后良好、美容效果佳、并发症少且恢复快,可与其他手术路径或辅助治疗联合用于复杂肿瘤,但该技术难度大,需专门的内镜手术技能,应限于专门中心开展。

研究设计与样本

  • 本机构2016年至2022年经eTOA治疗的蝶眶肿瘤患者纳入临床系列,共22例(女性16例,平均年龄57±13岁),并进行文献系统综述。

主要发现

  • eTOA术后全切除8例(36.4%),联合eTOA与内镜经鼻的多阶段策略后全切除11例(50.0%)。
  • 并发症包括1例慢性硬膜下血肿和1例永久性眼外肌缺陷,患者出院时间2.4±1.3天。
  • 最常见组织学类型为脑膜瘤(86.4%),突眼均改善,视力缺陷改善66.6%,复视改善76.9%。
  • 文献综述纳入127例报告病例,结果与本研究一致。

临床怎么用

  • 作者认为eTOA可用于蝶眶肿瘤,可与其他手术路径或辅助治疗联合用于复杂肿瘤,但该技术难度大,需专门的内镜手术技能,应限于专门中心开展。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transorbital neuroendoscopic surgery (TONES) comprises a group of approaches with indications expanding from orbital tumors to more complex skull base lesions. We analyzed the role of the endoscopic transorbital approach (eTOA) for spheno-orbital tumors, reporting the results of our clinical series and of a systematic review of the literature. MATERIALS AND METHODS: All patients operated on from 2016 to 2022 at our institution for a spheno-orbital tumor through an eTOA were included in a clinical series, and a systematic review of the literature was performed. RESULTS: Our series consisted of 22 patients (16 females, mean age 57 ± 13 years). Gross tumor removal was achieved in 8 patients (36.4%) after the eTOA and in 11 (50.0%) after a multistaged strategy combining the eTOA with the endoscopic endonasal approach. Complications included 1 chronic subdural hematoma and 1 permanent extrinsic ocular muscle deficit. Patients were discharged after 2.4 ± 1.3 days. The most common histotype was meningioma (86.4%). Proptosis improved in all cases, visual deficit in 66.6%, and diplopia in 76.9%. These results were confirmed by the review of the 127 cases reported in the literature. CONCLUSIONS: Despite its recent introduction, a significant number of spheno-orbital lesions treated with an eTOA are being reported. Its main advantages are favorable patient outcome and optimal cosmetic results, with minimal morbidity and quick recovery. This approach can be combined with other surgical routes or adjuvant therapies for complex tumors. However, it is a technically demanding procedure, requiring specific skills in endoscopic surgery, that should be reserved to dedicated centers.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Zoli M, Sollini G, Rustici A, et al. Endoscopic Transorbital Approach for Spheno-Orbital Tumors: Case Series and Systematic Review of Literature. World Neurosurg. 2023. PMID: 37331478. doi:10.1016/j.wneu.2023.06.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。